A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension

NCT00471380 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: travoprost 0.004% and brinzolamide 1%
DRUG: fixed combination of timolol 0.5% and dorzolamide 2% plus travoprost vehicle

Sponsor

Alcon Research